KYOWA KIRIN CO., LTD.

KYOWA KIRIN CO., LTD. logo
🇯🇵Japan
Ownership
Public, Subsidiary
Established
1949-07-01
Employees
5.9K
Market Cap
-
Website
http://www.kyowa-kirin.co.jp

Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2019-09-19
Last Posted Date
2022-05-26
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
24
Registration Number
NCT04095936
Locations
🇯🇵

NTT Medical center Tokyo, Shinagawa, Tokyo, Japan

A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

First Posted Date
2019-08-28
Last Posted Date
2019-11-29
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
20
Registration Number
NCT04070495
Locations
🇯🇵

Medical Co. LTA Sumida Hospital, Sumida-ku, Tokyo, Japan

A Study of KHK4827 in Subjects With Palmoplantar Pustulosis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2019-08-19
Last Posted Date
2023-02-14
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
126
Registration Number
NCT04061252
Locations
🇯🇵

Takagi Dermatology clinic, Obihiro, Hokkaido, Japan

🇯🇵

Sapporo Dermatology clinic, Sapporo, Hokkaido, Japan

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-07-18
Last Posted Date
2020-02-05
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
36
Registration Number
NCT04023903
Locations
🇯🇵

Medical Corporation Heishinkai OPHAC Hospital, Osaka, Japan

A Study of RTA 402 in Obese Adults

Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-07-12
Last Posted Date
2020-06-23
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
22
Registration Number
NCT04018339
Locations
🇯🇵

Applied Bio-Pharmatech Kurume Clinical Pharmacology Clinic, Kurume, Fukuoka, Japan

KRN125 for Mobilization of Hematopoietic Stem Cells

First Posted Date
2019-06-21
Last Posted Date
2021-01-22
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
35
Registration Number
NCT03993639
Locations
🇯🇵

Hokkaido University Hospital, Sapporo, Hokkaido, Japan

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2019-06-13
Last Posted Date
2024-07-17
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
14
Registration Number
NCT03985189
Locations
🇯🇵

The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

🇯🇵

Aomori Prefectural Central Hospital, Aomori, Japan

🇯🇵

Kyushu University Hospital, Fukuoka, Japan

and more 6 locations

A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin

First Posted Date
2019-06-03
Last Posted Date
2019-11-29
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
50
Registration Number
NCT03970798
Locations
🇯🇵

Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan

A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2019-05-21
Last Posted Date
2024-07-16
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
100
Registration Number
NCT03957681
Locations
🇯🇵

The University of Tokyo Hospital, Tokyo, Bunkyo-ku, Japan

🇯🇵

Chukyo Hospital, Nagoya, Aichi, Japan

🇯🇵

Osaka University Hospital, Suita, Osaka, Japan

and more 3 locations

Study of AMG531(Romiplostim) in Patients With Aplastic Anemia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2019-05-21
Last Posted Date
2022-05-26
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
17
Registration Number
NCT03957694
Locations
🇯🇵

Matsuyama Red Cross Hospital, Ehime, Japan

© Copyright 2024. All Rights Reserved by MedPath